Skip to main content
Top
Published in: Basic Research in Cardiology 5/2011

01-09-2011 | Original Contribution

Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload

Authors: Inês Falcão-Pires, Giuseppina Palladini, Nádia Gonçalves, Jolanda van der Velden, Daniel Moreira-Gonçalves, Daniela Miranda-Silva, Francesco Salinaro, Walter J. Paulus, Hans W. M. Niessen, Stefano Perlini, Adelino F. Leite-Moreira

Published in: Basic Research in Cardiology | Issue 5/2011

Login to get access

Abstract

Chronic pressure-overload and diabetes mellitus are two frequent disorders affecting the heart. We aimed to characterize myocardial structural and functional changes induced by both conditions. Pressure-overload was established in Wistar-han male rats by supra-renal aortic banding. Six-weeks later, diabetes was induced by streptozotocin (65 mg/kg,ip), resulting in four groups: SHAM, banding (BA), diabetic (DM) and diabetic-banding (DB). Six-weeks later, pressure–volume loops were obtained and left ventricular samples were collected to evaluate alterations in insulin signalling pathways, extracellular matrix as well as myofilament function and phosphorylation. Pressure-overload increased cardiomyocyte diameter (BA 22.0 ± 0.4 μm, SHAM 18.2 ± 0.3 μm) and myofilament maximal force (BA 25.7 ± 3.6 kN/m2, SHAM 18.6 ± 1.4 kN/m2), Ca2+ sensitivity (BA 5.56 ± 0.02, SHAM 5.50 ± 0.02) as well as MyBP-C, Akt and Erk phosphorylation, while decreasing rate of force redevelopment (K tr; BA 14.9 ± 1.1 s−1, SHAM 25.2 ± 1.5 s−1). At the extracellular matrix level, fibrosis (BA 10.8 ± 0.9%, SHAM 5.3 ± 0.6%), pro-MMP-2 and MMP-9 activities increased and, in vivo, relaxation was impaired (τ; BA 14.0 ± 0.9 ms, SHAM 12.9 ± 0.4 ms). Diabetes increased cardiomyocyte diameter, fibrosis (DM 21.4 ± 0.4 μm, 13.9 ± 1.8%, DB 20.6 ± 0.4 μm, 13.8 ± 0.8%, respectively), myofilament Ca2+sensitivity (DM 5.57 ± 0.02, DB 5.57 ± 0.01), advanced glycation end-product deposition (DM 4.9 ± 0.6 score/mm2, DB 5.1 ± 0.4 score/mm2, SHAM 2.1 ± 0.3 score/mm2), and apoptosis, while decreasing K tr (DM 13.5 ± 1.9 s−1, DB 15.2 ± 1.4 s−1), Akt phosphorylation and MMP-9/TIMP-1 and MMP-1/TIMP-1 ratios. Diabetic hearts were stiffer (higher end-diastolic-pressure: DM 7.0 ± 1.2 mmHg, DB 6.7 ± 0.7 mmHg, SHAM 5.3 ± 0.4 mmHg, steeper end-diastolic-pressure–volume relation: DM 0.59 ± 0.18, DB 0.83 ± 0.17, SHAM 0.41 ± 0.10), and hypo-contractile (decreased end-systolic-pressure-volume-relation). DB animals presented further pulmonary congestion (Lungs/body-weight: DB 5.23 ± 0.21 g/kg, SHAM 3.80 ± 0.14 g/kg) as this group combined overload-induced relaxation abnormalities and diabetes-induced stiffness. Diabetes mellitus and pressure overload led to distinct diastolic dysfunction phenotypes: while diabetes promoted myocardial stiffening, pressure overload impaired relaxation. The association of these damages accelerates the progression of diastolic heart failure progression in diabetic-banded animals.
Literature
1.
go back to reference Anversa P, Li P, Malhotra A, Zhang X, Herman MV, Capasso JM (1993) Effects of hypertension and coronary constriction on cardiac function, morphology, and contractile proteins in rats. Am J Physiol 265:H713–H724PubMed Anversa P, Li P, Malhotra A, Zhang X, Herman MV, Capasso JM (1993) Effects of hypertension and coronary constriction on cardiac function, morphology, and contractile proteins in rats. Am J Physiol 265:H713–H724PubMed
3.
go back to reference Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF (1999) Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22:1186–1190. doi:10.2337/diacare.22.7.1186 PubMedCrossRef Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF (1999) Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22:1186–1190. doi:10.​2337/​diacare.​22.​7.​1186 PubMedCrossRef
5.
go back to reference Brown RA, Filipovich P, Walsh MF, Sowers JR (1996) Influence of sex, diabetes and ethanol on intrinsic contractile performance of isolated rat myocardium. Basic Res Cardiol 91:353–360. doi:10.1007/BF00788714 PubMed Brown RA, Filipovich P, Walsh MF, Sowers JR (1996) Influence of sex, diabetes and ethanol on intrinsic contractile performance of isolated rat myocardium. Basic Res Cardiol 91:353–360. doi:10.​1007/​BF00788714 PubMed
7.
go back to reference Capasso JM, Palackal T, Olivetti G, Anversa P (1990) Left ventricular failure induced by long-term hypertension in rats. Circ Res 66:1400–1412PubMed Capasso JM, Palackal T, Olivetti G, Anversa P (1990) Left ventricular failure induced by long-term hypertension in rats. Circ Res 66:1400–1412PubMed
10.
go back to reference Dubrey SW, Reaveley DR, Seed M, Lane DA, Ireland H, O’Donnell M, O’Connor B, Noble MI, Leslie RD (1994) Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes 43:831–835PubMedCrossRef Dubrey SW, Reaveley DR, Seed M, Lane DA, Ireland H, O’Donnell M, O’Connor B, Noble MI, Leslie RD (1994) Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes 43:831–835PubMedCrossRef
12.
go back to reference Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14:1952–1960PubMed Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14:1952–1960PubMed
13.
go back to reference Grossman E, Messerli FH (1996) Diabetic and hypertensive heart disease. Ann Intern Med 125:304–310PubMed Grossman E, Messerli FH (1996) Diabetic and hypertensive heart disease. Ann Intern Med 125:304–310PubMed
15.
go back to reference Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229–H1235. doi:10.1152/ajpheart.00207.2003 PubMed Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229–H1235. doi:10.​1152/​ajpheart.​00207.​2003 PubMed
16.
go back to reference Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A (2006) Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 291:H2424–H2430. doi:10.1152/ajpheart.00369.2006 PubMedCrossRef Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A (2006) Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 291:H2424–H2430. doi:10.​1152/​ajpheart.​00369.​2006 PubMedCrossRef
18.
go back to reference Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135–1142. doi:10.1038/13459 PubMedCrossRef Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135–1142. doi:10.​1038/​13459 PubMedCrossRef
20.
go back to reference Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105:399–407. doi:10.1007/s00395-009-0071-x PubMedCrossRef Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105:399–407. doi:10.​1007/​s00395-009-0071-x PubMedCrossRef
21.
go back to reference Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455. doi:10.1007/BF01002772 PubMedCrossRef Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455. doi:10.​1007/​BF01002772 PubMedCrossRef
25.
go back to reference Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S (1990) Abnormal cardiac function in the streptozotocin-diabetic rat Changes in active and passive properties of the left ventricle. J Clin Invest 86:481–488. doi:10.1172/JCI114734 PubMedCrossRef Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S (1990) Abnormal cardiac function in the streptozotocin-diabetic rat Changes in active and passive properties of the left ventricle. J Clin Invest 86:481–488. doi:10.​1172/​JCI114734 PubMedCrossRef
27.
go back to reference Nagatomo Y, Carabello BA, Coker ML, McDermott PJ, Nemoto S, Hamawaki M, Spinale FG (2000) Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol 278:H151–H161PubMed Nagatomo Y, Carabello BA, Coker ML, McDermott PJ, Nemoto S, Hamawaki M, Spinale FG (2000) Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol 278:H151–H161PubMed
28.
go back to reference Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A, Nano R, Clari F, Busca G, Fogari R, Ferrari AU (2005) Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension 46:1213–1218 Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A, Nano R, Clari F, Busca G, Fogari R, Ferrari AU (2005) Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension 46:1213–1218
29.
31.
go back to reference Regan TJ, Khan MI, Ettinger PO, Haider B, Lyons MM, Oldewurtel HA (1974) Myocardial function and lipid metabolism in the chronic alcoholic animal. J Clin Invest 54:740–752. doi:10.1172/JCI107812 PubMedCrossRef Regan TJ, Khan MI, Ettinger PO, Haider B, Lyons MM, Oldewurtel HA (1974) Myocardial function and lipid metabolism in the chronic alcoholic animal. J Clin Invest 54:740–752. doi:10.​1172/​JCI107812 PubMedCrossRef
32.
go back to reference Ren J, Davidoff AJ (1997) Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272:H148–H158PubMed Ren J, Davidoff AJ (1997) Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272:H148–H158PubMed
33.
go back to reference Riva E, Andreoni G, Bianchi R, Latini R, Luvara G, Jeremic G, Traquandi C, Tuccinardi L (1998) Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 37:233–240. doi:10.1006/phrs.1998.0290 PubMedCrossRef Riva E, Andreoni G, Bianchi R, Latini R, Luvara G, Jeremic G, Traquandi C, Tuccinardi L (1998) Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 37:233–240. doi:10.​1006/​phrs.​1998.​0290 PubMedCrossRef
34.
go back to reference Rodgers RL, Davidoff AJ, Mariani MJ (1991) Cardiac function of the diabetic renovascular hypertensive rat: effects of insulin and thyroid hormone treatment. Can J Physiol Pharmacol 69:346–354. doi:10.1139/y91-053 PubMedCrossRef Rodgers RL, Davidoff AJ, Mariani MJ (1991) Cardiac function of the diabetic renovascular hypertensive rat: effects of insulin and thyroid hormone treatment. Can J Physiol Pharmacol 69:346–354. doi:10.​1139/​y91-053 PubMedCrossRef
36.
go back to reference Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL (2008) Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 103:60–68. doi:10.1007/s00395-007-0689-5 PubMedCrossRef Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL (2008) Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 103:60–68. doi:10.​1007/​s00395-007-0689-5 PubMedCrossRef
37.
go back to reference Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW (2004) Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta 1636:82–89PubMed Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW (2004) Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta 1636:82–89PubMed
40.
go back to reference Sweeney HL, Bowman BF, Stull JT (1993) Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol 264:C1085–C1095PubMed Sweeney HL, Bowman BF, Stull JT (1993) Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol 264:C1085–C1095PubMed
41.
go back to reference Tomlinson KC, Gardiner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103–150PubMed Tomlinson KC, Gardiner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103–150PubMed
42.
go back to reference Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R, Perlini S (2007) Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypertens 20:663–669. doi:10.1016/j.amjhyper.2007.01.016 PubMedCrossRef Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R, Perlini S (2007) Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypertens 20:663–669. doi:10.​1016/​j.​amjhyper.​2007.​01.​016 PubMedCrossRef
44.
go back to reference van Hoeven KH, Factor SM (1990) A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82:848–855PubMedCrossRef van Hoeven KH, Factor SM (1990) A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82:848–855PubMedCrossRef
45.
go back to reference Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Bohm M, Pauschinger M, Schultheiss HP, Tschope C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103:319–327. doi:10.1007/s00395-008-0715-2 PubMedCrossRef Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Bohm M, Pauschinger M, Schultheiss HP, Tschope C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103:319–327. doi:10.​1007/​s00395-008-0715-2 PubMedCrossRef
46.
go back to reference Volz HC, Seidel C, Laohachewin D, Kaya Z, Muller OJ, Pleger ST, Lasitschka F, Bianchi ME, Remppis A, Bierhaus A, Katus HA, Andrassy M (2010) HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol 105:805–820. doi:10.1007/s00395-010-0114-3 PubMedCrossRef Volz HC, Seidel C, Laohachewin D, Kaya Z, Muller OJ, Pleger ST, Lasitschka F, Bianchi ME, Remppis A, Bierhaus A, Katus HA, Andrassy M (2010) HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol 105:805–820. doi:10.​1007/​s00395-010-0114-3 PubMedCrossRef
47.
go back to reference Weisberg A, Winegrad S (1998) Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ Res 83:60–72PubMed Weisberg A, Winegrad S (1998) Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ Res 83:60–72PubMed
48.
go back to reference Whittaker P, Kloner RA, Boughner DR, Pickering JG (1994) Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89:397–410. doi:10.1007/BF00788278 PubMedCrossRef Whittaker P, Kloner RA, Boughner DR, Pickering JG (1994) Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89:397–410. doi:10.​1007/​BF00788278 PubMedCrossRef
49.
go back to reference Wiesner RJ, Ehmke H, Faulhaber J, Zak R, Ruegg JC (1997) Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 95:1253–1259PubMed Wiesner RJ, Ehmke H, Faulhaber J, Zak R, Ruegg JC (1997) Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 95:1253–1259PubMed
50.
go back to reference Yang B, Larson DF, Watson R (1999) Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol 277:H1906–H1913PubMed Yang B, Larson DF, Watson R (1999) Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol 277:H1906–H1913PubMed
51.
go back to reference Zaremba R, Merkus D, Hamdani N, Lamers JML, Paulus WJ, dos Remedios C, Duncker DJ, Stienen GJM, van der Velden J (2007) Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl 1:1285. doi:10.1002/prca.200600891 PubMedCrossRef Zaremba R, Merkus D, Hamdani N, Lamers JML, Paulus WJ, dos Remedios C, Duncker DJ, Stienen GJM, van der Velden J (2007) Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl 1:1285. doi:10.​1002/​prca.​200600891 PubMedCrossRef
Metadata
Title
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload
Authors
Inês Falcão-Pires
Giuseppina Palladini
Nádia Gonçalves
Jolanda van der Velden
Daniel Moreira-Gonçalves
Daniela Miranda-Silva
Francesco Salinaro
Walter J. Paulus
Hans W. M. Niessen
Stefano Perlini
Adelino F. Leite-Moreira
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Basic Research in Cardiology / Issue 5/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-011-0184-x

Other articles of this Issue 5/2011

Basic Research in Cardiology 5/2011 Go to the issue